Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Tai Chi Practitioner; Qigong Practitioner
Intervention:
Sponsor: The Hong Kong Polytechnic University
Completed - verified August 2008
Condition: Atrial Fibrillation
Intervention:
Sponsor: University of Athens
Active, not recruiting - verified March 2010
Condition: Stem Cell Transplantation
Interventions: Biological: Auto-hMSCs; Biological: Allo-hMSCs
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); University of Miami
Not yet recruiting - verified October 2009
Condition: Hypertension
Interventions: Drug: Perindopril; Drug: Perindopril/amlodipine; Drug: Olmesartan/amlodipine
Sponsors: Monash University; Schering-Plough
Not yet recruiting - verified March 2010
Condition: Surgery
Intervention:
Sponsor: Baylor Research Institute
Recruiting - verified March 2010
Conditions: Cardiac Surgery; Infection, Postoperative Wound; Postoperative Wound Infection; Infections, Nosocomial; Management Practices
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health Research (CIHR); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2010
Condition: Diagnostic Imaging
Interventions: Drug: BAY86-9596; Drug: BAY86-9596; Drug: BAY86-9596
Sponsor: Bayer
Not yet recruiting - verified March 2010
Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
Sponsors: Dana-Farber Cancer Institute; Brigham and Women's Hospital; Children's Hospital Boston; Washington University School of Medicine; LaJolla Institute for Allergy and Immunology; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified March 2010
Conditions: Hyperlipidemia; Health
Interventions: Drug: Fish oil; Drug: Placebo (corn oil)
Sponsor: Gottfried Wilhelm Leibniz Universität Hannover
Not yet recruiting - verified March 2010
Condition: Coronary Artery Disease
Interventions: Drug: atorvastatin; Drug: atorvastatin plus ezetimibe
Sponsor: Shanghai Jiao Tong University School of Medicine
Recruiting - verified December 2009
Condition: Coronary Artery Disease
Intervention: Drug: Omacor, omega-3 fatty acids in CAD patients
Sponsors: HeartDrug Research LLC; University of Oslo
Not yet recruiting - verified March 2010
Conditions: Platelet Activation; Blood Coagulation
Intervention: Drug: Low molecular weight heparin
Sponsors: Third Military Medical University; Chongqing Medical University
Enrolling by invitation - verified March 2010
Condition: Blood Pressure
Intervention:
Sponsors: Christiana Care Health Services; University of Delaware
Not yet recruiting - verified March 2010
Condition: Fibromyalgia
Intervention: Drug: Duloxetine
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Coronary Artery Disease
Interventions: Other: Remote ischemic preconditioning; Other: Sham Remote Ischemic Preconditioning
Sponsor: St. Francis Hospital, New York
Not yet recruiting - verified February 2010
Condition: Transfusional Hemosiderosis in Sickle Cell Disease
Intervention: Drug: ICL670
Sponsor: Novartis Pharmaceuticals
Completed - verified March 2010
Condition: Hypertension
Interventions: Drug: Bisoprolol; Drug: Atenolol
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Diabetic Neuropathy, Painful
Interventions: Drug: Duloxetine; Drug: Pregabalin; Drug: Placebo
Sponsors: Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Primary Hyperparathyroidism
Intervention: Procedure: Parathyroid surgery
Sponsor: Region Skane
Not yet recruiting - verified March 2010
Condition: Coronary Artery Disease
Interventions: Behavioral: Educational Intervention - Text plus DVD/VHS; Behavioral: Educational Intervention - Text Only
Sponsors: University of Cincinnati; Foundation for Informed Medical Decision Making
Completed - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: Congenital Heart Disease
Intervention:
Sponsors: University of Texas Southwestern Medical Center; The University of Texas at Arlington
Not yet recruiting - verified March 2010
Condition: Hypertrophic Cardiomyopathy
Intervention: Procedure: additional temporary pacewire
Sponsor: Johann Wolfgang Goethe University Hospitals
Not yet recruiting - verified March 2010
Condition: Cardiac Dysrhythmia
Intervention:
Sponsors: University of Dundee; NHS Tayside
Active, not recruiting - verified March 2010
Conditions: Heart Disease; Liver Failure; Depressive Disorder; Alcoholic Neuropathy
Intervention: Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Sponsor: Levanger Hospital
Recruiting - verified January 2010
Conditions: Valvular Surgery; Critically Ill
Interventions: Drug: Potassium Chloride; Drug: Potassium Chloride
Sponsor: University Medical Centre Groningen
Recruiting - verified March 2010
Condition: CVD
Intervention: Behavioral: Dietician electonic support
Sponsors: Group Health Cooperative; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: CMX157; Drug: Placebo; Drug: Viread
Sponsor: Chimerix
Not yet recruiting - verified March 2010
Condition: Infant, Small for Gestational Age
Intervention: Drug: recombinant somatropin
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Hypertension
Intervention: Drug: Lodoz (Combination of bisoprolol and hydrochlorothiazide)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Hemorrhage
Interventions: Drug: Indomethacin; Drug: Acetaminophen & Indomethacin; Drug: Acetaminophen
Sponsor: Queen's University
Completed - verified February 2010
Condition: Heart Arrest
Intervention: Other: Preemptive Rapid Response Team intervention
Sponsors: University of Chicago; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Condition: Heart Failure
Intervention: Drug: AMG 423
Sponsor: Amgen
Not yet recruiting - verified February 2010
Condition: Anaemia
Interventions: Drug: IV trivalent saccharose hydroxide ferrous; Drug: Oral ferrous fumarate; Drug: Oral and intravenous Placebo
Sponsor: Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Completed - verified May 2007
Condition: Malaria
Intervention: Biological: Immunization with P. vivax irradiated sporozoites
Sponsors: Malaria Vaccine and Drug Development Center; National Heart, Lung, and Blood Institute (NHLBI); Asoclinic Laboratorio de Inmunología
Not yet recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Nebivolol; Drug: Lisinopril
Sponsor: University of Mississippi Medical Center
Recruiting - verified February 2010
Conditions: Coronary Artery Disease; Atherosclerosis
Interventions: Device: zotarolimus-eluting stent (ENDEAVOR®); Device: sirolimus-eluting stents (CYPHER SELECT® PLUS); Device: everolimus-eluting stents (PROMUS®)
Sponsor: Hyogo College of Medicine
Not yet recruiting - verified February 2010
Condition: Ischaemia-reperfusion (IR) Injury
Interventions: Drug: C-type natriuretic peptide (CNP); Drug: Saline; Drug: Acetylcholine
Sponsors: Queen Mary University of London; University College, London
Not yet recruiting - verified February 2010
Condition: Cardiac Surgery
Interventions: Procedure: Remote Ischemic Preconditioning; Procedure: Sham
Sponsors: Hamilton Health Sciences; Canadian Network and Centre for Trials Internationally
Not yet recruiting - verified January 2010
Condition: Neuromuscular Disease
Interventions: Drug: A0001 (alpha-tocopherolquinone); Drug: Placebo
Sponsor: Penwest Pharmaceuticals Co.
Recruiting - verified February 2010
Condition: Blood Pressure
Interventions: Drug: stop ace-i/arb 24 h before procedure and restarted 24 hours after the procedure; Drug: ACE/ARB stopped 24 hours before procedure and start immediately after
Sponsor: Soroka University Medical Center
Not yet recruiting - verified February 2010
Condition: Respiratory Failure
Interventions: Drug: dexmedetomidine; Procedure: Vital signs; Procedure: blood sampling
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Diabetes Type 2
Interventions: Drug: Insulin-Levemir; Drug: Exenatide-Bayetta; Drug: Insulin-Levemir and Exenatide-Bayetta; Device: SenseWear Pro3® armband; Device: DexCom CGM
Sponsors: Novo Nordisk; BodyMedia
Recruiting - verified June 2009
Condition: Traumatic Brain Injury
Intervention:
Sponsors: University of Cincinnati; Department of Defense
Not yet recruiting - verified February 2010
Condition: Type 1 Diabetes
Interventions: Other: Closed-loop insulin delivery; Other: Standard insulin pump treatment
Sponsors: University of Cambridge; Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting - verified February 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Biological: REGN727; Biological: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi-Aventis
Not yet recruiting - verified February 2010
Condition: Myocardial Tissue in Heart Transplantation
Intervention: Dietary Supplement: Fish Oil
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified February 2010
Conditions: Bone Marrow; Bone Marrow Stromal Cells; Mesenchymal Stem Cells; Blood Donors
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified January 2010
Condition: Ischemia
Intervention: Drug: ambrisentan
Sponsors: The Cleveland Clinic; Gilead Sciences
Recruiting - verified February 2010
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
Sponsors: University of Michigan; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (info added by University of Michigan Data Coordinating Center)
Recruiting - verified November 2009
Condition: Sedation
Interventions: Device: Patient-controlled sedation; Device: Target-controlled infusion
Sponsor: Helsinki University Central Hospital
Recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Non-ARB (standard therapy); Drug: ARB (Telmisartan)
Sponsor: Kumamoto University
Recruiting - verified June 2009
Condition: Macular Degeneration
Interventions: Drug: pazopanib; Drug: pazopanib; Drug: pazopanib; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Sickle Cell Disease
Interventions: Drug: Propranolol; Drug: Placebo
Sponsors: Duke University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified February 2010
Conditions: Sedentary Lifestyle; Risk of Disability; Aging
Intervention: Behavioral: Lifestyle modification
Sponsors: University of Florida; National Institute on Aging (NIA); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
